Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity.
Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz MA, Golding L, Karim ME, Barakauskas V, Wall N, Jassem AN, Marquez AC, MacDonald C, O'Brien SF, Lavoie P, Grunau B.
Asamoah-Boaheng M, et al. Among authors: barakauskas v.
Cureus. 2023 Jan 31;15(1):e34465. doi: 10.7759/cureus.34465. eCollection 2023 Jan.
Cureus. 2023.
PMID: 36874687
Free PMC article.